Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
2018 · Cancer Treatment Reviews · 255 citations
https://doi.org/10.1016/j.ctrv.2018.06.005
M
Mario Giuliano
Regione Campania(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
285
Papers
7.5K
Citations
45
h-index
95
i10-index
Mario Giuliano is an academic researcher from Regione Campania. The author has contributed to research in topics: Cancer Cells and Metastasis & Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research. The author has an h-index of 45, co-authored 243 publications.
ORCID: 0000-0003-0835-3153Papers by this author
worksCirculating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
2011 · Breast Cancer Research · 224 citations
https://doi.org/10.1186/bcr2907
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
2019 · The Lancet Oncology · 189 citations
https://doi.org/10.1016/s1470-2045(19)30420-6
Mechanisms of lapatinib resistance in HER2-driven breast cancer
2015 · Cancer Treatment Reviews · 160 citations
https://doi.org/10.1016/j.ctrv.2015.08.001
Relationship Between Lymphocytopenia and Circulating Tumor Cells as Prognostic Factors for Overall Survival in Metastatic Breast Cancer
2012 · Clinical Breast Cancer · 123 citations
https://doi.org/10.1016/j.clbc.2012.04.004
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
2014 · Breast Cancer Research · 122 citations
https://doi.org/10.1186/s13058-014-0440-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat